lactose has been researched along with Bone Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, H; Eriksen, EF; Jensen, ON; Moiseeva, EP | 1 |
Clar, H; Clar, V; Gruber, G; Hofmann, G; Krippl, P; Langsenlehner, T; Langsenlehner, U; Leithner, A; Renner, W; Windhager, R; Yazdani-Biuki, B | 1 |
2 other study(ies) available for lactose and Bone Cancer
Article | Year |
---|---|
A proteome study of secreted prostatic factors affecting osteoblastic activity: galectin-1 is involved in differentiation of human bone marrow stromal cells.
Topics: Bone Marrow Cells; Bone Neoplasms; Cell Adhesion; Cell Differentiation; Cell Division; Collagen; Collagen Type I; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Fibronectins; Galectin 1; Humans; Lactose; Laminin; Male; Neoplasm Metastasis; Osteoblasts; Peptide Mapping; Prostatic Neoplasms; Proteome; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured | 2003 |
The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Female; Genotype; Humans; Lactose; Middle Aged; Neoplasm Metastasis; Osteoporosis; Polymorphism, Genetic; Risk Factors | 2008 |